ArticleTurkish journal of medical sciences2023

Impact of 24-week dapagliflozin treatment on body weight, body composition, and cardiac risk indicators of patients with type-2 diabetes mellitus.

Pınar Akhanli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.